SMTL ID : 9uhi.2 (1 other biounit)

FGFR1 kinase domain with a covalent inhibitor 9o

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.76 Å

Oligo State

monomer

Ligands

1 x 01: ~{N}-[1-methyl-3-[3-[1-(2-morpholin-4-ylethyl)pyrazol-4-yl]quinoxalin-5-yl]indol-6-yl]propanamide

01.1: 16 residues within 4Å: Chain A: L.29, G.30, E.31, G.32, C.33, V.37, A.57, V.106, E.107, Y.108, A.109, S.110, G.112, N.173, L.175, D.186 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:V.37, A:A.57, A:V.106, A:L.175 Hydrogen bonds: A:C.33, A:A.109, A:N.173

1 x SO4: SULFATE ION(Non-functional Binders)

SO4.2: 2 residues within 4Å: Chain A: K.87, R.154 4 PLIP interactions: 4 interactions with chain A Water bridges: A:N.88, A:R.154 Salt bridges: A:K.87, A:R.154

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Deng, W. et al., Design, Synthesis and Biological Evaluation of 7-(1-Methyl-1 H -indole-3-yl)-5 H -pyrrolo[2,3- b ]pyrazine Derivatives as Novel Covalent pan-FGFR Inhibitors to Overcome Clinical Resistance. J.Med.Chem. (2025)

Release Date

2025-09-24

Peptides

Fibroblast growth factor receptor 1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Fibroblast growth factor receptor 1

Related Entries With Identical Sequence